Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. DPOH name: LEBLANC, JOSEE
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Refine monthly communication reports results by

Type Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (2)
Results: 1-2 | Export
  1. Hoffmann-La Roche Limited
    Type: In-house Corporation
    Occurred: 2023-09-26
    Posted: 2023-10-15
    Designated public office holders:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Daniel MacDonald, Director General, Drugs for Rare Diseases, Strategic Policy Branch | Health Canada (HC)
    • Andrew Taylor, Director | Health Canada (HC)
    • Josee LeBlanc, Senior Policy Analyst | Health Canada (HC)
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Mark Schaan, Assistant Deputy Minister, Strategy & Innovation Policy Sector | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  2. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Occurred: 2023-07-04
    Posted: 2023-08-15
    Designated public office holders:
    • Andrew Taylor, Senior Policy Advisor | Health Canada (HC)
    • Daniel MacDonald, Director General, Drugs for Rare Diseases, Strategic Policy Branch | Health Canada (HC)
    • Josee Leblanc, Senior Policy Advisor | Health Canada (HC)
    • Christine Ung, Policy Advisor | Health Canada (HC)
    Subject matters:
    • Science and Technology
    • Research and Development
    • Health
      •
Date Modified: